![Alan George Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan George Clark
Direttore Tecnico/Scientifico/R&S presso TCB Newco Ltd.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Michael Leek | M | 64 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Angela Scott | F | 60 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Martin Thorp | M | 72 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Kimihito Minoura | M | 51 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Derek Cameron Leslie | M | 60 |
Glykogen Ltd.
![]() Glykogen Ltd. Pharmaceuticals: MajorHealth Technology Glykogen Ltd. engages in the development of anti-glycan monoclonal antibodies using a novel and innovative process. The company was founded on October 11, 2016 and is headquartered in Fife, the United Kingdom. | 7 anni |
Lorraine Christie Porter | F | - |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Kimberley Jane Mackenzie | M | 43 |
Glykogen Ltd.
![]() Glykogen Ltd. Pharmaceuticals: MajorHealth Technology Glykogen Ltd. engages in the development of anti-glycan monoclonal antibodies using a novel and innovative process. The company was founded on October 11, 2016 and is headquartered in Fife, the United Kingdom. | 8 anni |
Fiona Penelope Jane Smith | F | 58 |
Glykogen Ltd.
![]() Glykogen Ltd. Pharmaceuticals: MajorHealth Technology Glykogen Ltd. engages in the development of anti-glycan monoclonal antibodies using a novel and innovative process. The company was founded on October 11, 2016 and is headquartered in Fife, the United Kingdom. | 7 anni |
Bryan Kobel | M | 44 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Dorothy Lister | F | 63 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Toby Rintoul | M | 52 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Sebastian Wanless | M | 68 |
TCB Newco Ltd.
![]() TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Theodore Hupp | M | 62 |
Luperacus Ltd.
![]() Luperacus Ltd. BiotechnologyHealth Technology Luperacus Ltd. develops novel therapeutic antibodies to treat canine and human cancer. The company was founded by Alan G. Clark and is headquartered in Glasgow, the United Kingdom. | 1 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 13 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Alan George Clark
- Contatti personali